Ignite Creation Date:
2024-05-05 @ 11:33 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00071448
Status:
COMPLETED
Last Update Posted:
2016-12-22
First Post:
2003-10-23
Brief Title:
Insulin Aspart vs Insulin Lispro vs Regular Insulin in Paediatric Population
Sponsor:
Novo Nordisk AS
Organization:
Novo Nordisk AS
Study Overview
Official Title:
BasalBolus Therapy With Insulin Aspart NovoLog Versus Regular Human Insulin Novolin R or Insulin Lispro Humalog in Combination With NPH An Open-Label Randomized Parallel Group Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status:
COMPLETED
Status Verified Date:
2016-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This trial is conducted in the United States of America USA The aim of this trial is to to determine whether insulin aspart can be used effectively and safely in paediatric patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None